These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 16924166

  • 1. Nebivolol: new therapy update.
    Sule SS, Frishman W.
    Cardiol Rev; 2006; 14(5):259-64. PubMed ID: 16924166
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 3. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A, Nuzum DS, Jolly JL.
    Ann Pharmacother; 2006 Mar; 40(7-8):1353-60. PubMed ID: 16822893
    [Abstract] [Full Text] [Related]

  • 4. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 5. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators.
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [Abstract] [Full Text] [Related]

  • 7. [Nebivolol: a beta blocker with vasodilator properties].
    Waeber B.
    Praxis (Bern 1994); 2000 Apr 06; 89(15):631-3. PubMed ID: 10804847
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol: the somewhat-different beta-adrenergic receptor blocker.
    Münzel T, Gori T.
    J Am Coll Cardiol; 2009 Oct 13; 54(16):1491-9. PubMed ID: 19815121
    [Abstract] [Full Text] [Related]

  • 9. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM, Keam SJ.
    Am J Cardiovasc Drugs; 2009 Jul 27; 9(4):253-60. PubMed ID: 19655820
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide mechanisms of nebivolol.
    Maffei A, Lembo G.
    Ther Adv Cardiovasc Dis; 2009 Aug 27; 3(4):317-27. PubMed ID: 19443516
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct 27; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

  • 13. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE, Philipp T.
    Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442
    [Abstract] [Full Text] [Related]

  • 14. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I.
    Adv Ther; 2008 Sep 10; 25(9):871-83. PubMed ID: 18758699
    [Abstract] [Full Text] [Related]

  • 15. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM.
    J Cardiovasc Pharmacol; 1993 Jun 15; 21(6):856-62. PubMed ID: 7687708
    [Abstract] [Full Text] [Related]

  • 17. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.